We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$393B
AUM Growth
+$46.5B
Cap. Flow
+$16.2B
Cap. Flow %
4.12%
Top 10 Hldgs %
14.79%
Holding
5,596
New
456
Increased
2,467
Reduced
1,888
Closed
410

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.23B
2
AMZN icon
Amazon
AMZN
+$792M
3
V icon
Visa
V
+$508M
4
T icon
AT&T
T
+$423M
5
JNJ icon
Johnson & Johnson
JNJ
+$422M

Sector Composition

Rank Sector Weight
1 Technology 13.44%
2 Financials 10.8%
3 Healthcare 10.08%
4 Consumer Discretionary 7.71%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERII icon
4326
Energy Recovery
ERII
$446M
$612K ﹤0.01%
62,602
+42,676
+214% +$393K
FTXO icon
4327
First Trust Nasdaq Bank ETF
FTXO
$305M
$612K ﹤0.01%
21,731
APLS
4328
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$609K ﹤0.01%
+19,900
New +$551K
FMK
4329
DELISTED
First Trust Mega Cap AlphaDEX Fund
FMK
$609K ﹤0.01%
15,866
FUNC icon
4330
First United
FUNC
$285M
$608K ﹤0.01%
25,250
+2,955
+13% +$70K
PBPB
4331
DELISTED
Potbelly
PBPB
$606K ﹤0.01%
143,619
+120,599
+524% +$526K
SABA
4332
Saba Capital Income & Opportunities Fund II
SABA
$220M
$606K ﹤0.01%
+49,422
New +$596K
VYMI icon
4333
Vanguard International High Dividend Yield ETF
VYMI
$20.6B
$606K ﹤0.01%
9,500
-14,500
-60% -$896K
O icon
4334
PUT
Realty Income
O
$59.6B
$604K ﹤0.01%
8,462
INO icon
4335
Inovio Pharmaceuticals
INO
$55.7M
$603K ﹤0.01%
15,231
+6,715
+79% +$202K
SQLV icon
4336
Royce Quant Small-Cap Quality Value ETF
SQLV
$29.2M
$602K ﹤0.01%
21,550
NE
4337
DELISTED
Noble Corporation
NE
$602K ﹤0.01%
493,992
+9,580
+2% +$11.5K
ETNB
4338
DELISTED
89bio
ETNB
$600K ﹤0.01%
+22,836
New +$635K
PFM icon
4339
Invesco Dividend Achievers ETF
PFM
$791M
$600K ﹤0.01%
19,552
LXRX icon
4340
Lexicon Pharmaceuticals
LXRX
$1.03B
$599K ﹤0.01%
144,392
-39,720
-22% -$153K
PRO
4341
PUT
DELISTED
PROS Holdings
PRO
$599K ﹤0.01%
10,000
-553,700
-98% -$31.9M
TLRD
4342
DELISTED
Tailored Brands, Inc.
TLRD
$599K ﹤0.01%
144,792
-160,712
-53% -$756K
NERV icon
4343
Minerva Neurosciences
NERV
$185M
$597K ﹤0.01%
10,503
-253
-2% -$11.2K
EVBN
4344
DELISTED
Evans Bancorp Inc
EVBN
$596K ﹤0.01%
14,857
+2,336
+19% +$91K
PTH icon
4345
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$221M
$594K ﹤0.01%
+18,612
New +$529K
VEON icon
4346
VEON
VEON
$3.62B
$594K ﹤0.01%
9,397
-6,524
-41% -$401K
GHM icon
4347
Graham Corp
GHM
$1.12B
$592K ﹤0.01%
27,054
+3,189
+13% +$68.9K
FSTR icon
4348
Foster
FSTR
$430M
$585K ﹤0.01%
30,183
+751
+3% +$14.6K
AVID
4349
DELISTED
Avid Technology Inc
AVID
$585K ﹤0.01%
68,284
+32,338
+90% +$238K
CRVS icon
4350
Corvus Pharmaceuticals
CRVS
$1.12B
$583K ﹤0.01%
107,176
+47,293
+79% +$165K

Similar funds

Goldman Sachs's Q4 2019 Portfolio in Review

As of Q4 2019, Goldman Sachs held 5,596 positions worth $393B, up 13% from $346B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Goldman Sachs deployed $16.2B of net new capital in Q4 2019, opening 456 new positions and adding to 2,467 existing holdings. Its largest new stake was Sprout Social: 10,378,809 shares worth $167M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.19B trimmed.

  • Goldman Sachs's largest Q4 2019 buy was Sprout Social: 10,378,809 shares worth $167M.
  • Goldman Sachs added most to Microsoft in Q4 2019, an estimated $1.23B increase.
  • Goldman Sachs's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.19B.
  • Goldman Sachs fully exited Celgene Corp in Q4 2019, selling an estimated $740M.
  • Goldman Sachs's ten largest holdings make up 15% of its $393B portfolio in Q4 2019.
  • Goldman Sachs opened 456 new positions and closed 410 in Q4 2019.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $393B.

Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.